CVRx, Inc.

As of April 22, 2025, CVRx, Inc. is in a bearish trend, indicated by negative MACD, Bollinger Bands, and moving averages, along with significant underperformance compared to the S&P 500.

CVRx, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $12 million and a net loss of $14 million as of March 2025, with a market cap of $147.57 million. Key financial metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of -74.32%.

As of Jun 18, CVRx, Inc. has a market capitalization of 147.57 million, with net sales of 52.87 million and a consolidated net profit of -51.55 million over the last four quarters. Shareholder's funds total 71.06 million, and total assets are reported at 133.41 million.